Skip to main content
Clinical Trials/NCT02040701
NCT02040701
Unknown
Not Applicable

Sleep Disordered Breathing in Children: Inflammation and Oxidative Stress

Tel-Aviv Sourasky Medical Center1 site in 1 country300 target enrollmentMay 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Disordered Breathing (SDB)
Sponsor
Tel-Aviv Sourasky Medical Center
Enrollment
300
Locations
1
Primary Endpoint
Plasma inflammatory-markers
Last Updated
12 years ago

Overview

Brief Summary

The purpose of the study is to measure markers of inflammatory and oxidative stress known to be associated with cardiovascular morbidity in snoring children.

In addition, to measure markers of local inflammation and to evaluate the response to treatment.

Registry
clinicaltrials.gov
Start Date
May 2006
End Date
May 2014
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • children ages 6 months-18 years
  • suspected sleep-disordered breathing or will attend the pre-operative ENT clinic for adenoidectomy or adenotonsillectomy

Exclusion Criteria

  • craniofacial abnormalities
  • neurological disorders
  • genetic disorders
  • infectious disease
  • chronic inflammatory disease
  • any underlying chronic medical condition

Outcomes

Primary Outcomes

Plasma inflammatory-markers

Time Frame: After the blood analyzed

Sleep disordered breathing (SDB) in children is associated with increased markers of inflammation, atherogenesis and oxidative stress.

Study Sites (1)

Loading locations...

Similar Trials